We used K562 chronic myeloid leukemia cells to study NGLY1 deficiency because these cells are easy to handle, simple to manipulate, and express endogenous NGLY1 at a relatively high level (Uhlen et al. 2015). This evidence concerns the gene NGLY1 and chronic myelogenous leukemia, BCR-ABL1 positive.